DK114791A - Fremgangsmaade til fremstilling af et antistof mod hbsag - Google Patents

Fremgangsmaade til fremstilling af et antistof mod hbsag Download PDF

Info

Publication number
DK114791A
DK114791A DK114791A DK114791A DK114791A DK 114791 A DK114791 A DK 114791A DK 114791 A DK114791 A DK 114791A DK 114791 A DK114791 A DK 114791A DK 114791 A DK114791 A DK 114791A
Authority
DK
Denmark
Prior art keywords
yeast
hbsag
synthesis
purified
particles
Prior art date
Application number
DK114791A
Other languages
English (en)
Other versions
DK114791D0 (da
DK169152B1 (da
Inventor
William J Rutter
Pablo D T Valenzuela
Benjamin D Hall
Gustav Ammerer
Original Assignee
Univ California
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23113710&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK114791(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ California, Univ Washington filed Critical Univ California
Publication of DK114791D0 publication Critical patent/DK114791D0/da
Publication of DK114791A publication Critical patent/DK114791A/da
Application granted granted Critical
Publication of DK169152B1 publication Critical patent/DK169152B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK114791A 1981-08-04 1991-06-14 Fremgangsmåde til fremstilling af et antistof mod HBsAg DK169152B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28991581A 1981-08-04 1981-08-04
US28991581 1981-08-04

Publications (3)

Publication Number Publication Date
DK114791D0 DK114791D0 (da) 1991-06-14
DK114791A true DK114791A (da) 1991-06-14
DK169152B1 DK169152B1 (da) 1994-08-29

Family

ID=23113710

Family Applications (2)

Application Number Title Priority Date Filing Date
DK347682A DK163931C (da) 1981-08-04 1982-08-03 Fremgangsmaade til fremstilling af hbsag, en dna-vektor og en gaercelle indeholdende denne dna-vektor til brug ved fremgangsmaaden
DK114791A DK169152B1 (da) 1981-08-04 1991-06-14 Fremgangsmåde til fremstilling af et antistof mod HBsAg

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK347682A DK163931C (da) 1981-08-04 1982-08-03 Fremgangsmaade til fremstilling af hbsag, en dna-vektor og en gaercelle indeholdende denne dna-vektor til brug ved fremgangsmaaden

Country Status (12)

Country Link
EP (1) EP0072318B1 (da)
JP (1) JPS5877823A (da)
AT (1) ATE123225T1 (da)
CA (1) CA1341642C (da)
DE (2) DE3280186D1 (da)
DK (2) DK163931C (da)
ES (1) ES514712A0 (da)
GR (1) GR76274B (da)
HK (1) HK64591A (da)
IE (1) IE65996B1 (da)
PT (1) PT75374B (da)
SG (1) SG58191G (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
JPS58146281A (ja) * 1981-10-19 1983-08-31 Suntory Ltd 酵母細胞の形質転換法
DE3381619D1 (de) * 1982-08-16 1990-07-05 Chemo Sero Therapeut Res Inst Pendelvektor.
IL69202A (en) * 1982-09-08 1991-08-16 Smith Kline Rit Surface antigen polypeptides of hbv virus produced in yeast and the preparation thereof
US4876197A (en) * 1983-02-22 1989-10-24 Chiron Corporation Eukaryotic regulatable transcription
CA1341302C (en) * 1983-02-22 2001-10-09 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis of foreign protein
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
JPS60104020A (ja) * 1983-10-14 1985-06-08 メルク　エンド　カムパニー　インコーポレーテツド Ａ型肝炎‐タンパク質サブユニツト抗原
EP0480480A3 (en) * 1984-05-11 1992-06-10 Chiron Corporation Enhanced yeast transcription employing hybrid promoter region constructs
EP0174444B1 (en) * 1984-06-18 1992-03-11 Chiron Corporation Hepatitis surface antigen particle vaccine
US4624918A (en) * 1984-07-09 1986-11-25 Genentech, Inc. Purification process for hepatitis surface antigen and product thereof
DE3584866D1 (de) * 1984-09-12 1992-01-23 Chiron Corp Hybridpartikel-immunogene.
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens
EP0225887B1 (en) * 1985-04-08 1994-06-08 Amgen Inc. A method and a hybrid promoter for controlling exogenous gene transcription
US4649192A (en) * 1985-05-30 1987-03-10 Smith Kline-Rit Method for the isolation and purification of hepatitis B surface antigen using polysorbate
CA1288075C (en) * 1985-08-15 1991-08-27 John C. Fieschko Fermentation methods for hepatitis vaccine production
JP2810364B2 (ja) * 1985-10-04 1998-10-15 ジ・アップジョン・カンパニー 偽狂犬病ウイルス蛋白質
US4935349A (en) * 1986-01-17 1990-06-19 Zymogenetics, Inc. Expression of higher eucaryotic genes in aspergillus
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
JPH0768267B2 (ja) * 1986-06-05 1995-07-26 財団法人阪大微生物病研究会 フラビウイルス抗原
JPH089637B2 (ja) * 1986-06-18 1996-01-31 財団法人阪大微生物病研究会 Ｂ型肝炎ウイルス抗原とその製造法
JPH0789951B2 (ja) * 1986-06-18 1995-10-04 財団法人阪大微生物病研究会 遺伝子発現産物の精製法
IL79740A0 (en) * 1986-08-17 1986-11-30 Yeda Res & Dev Hepatitis vaccine
EP0329671B1 (en) * 1986-11-01 1994-01-12 British Bio-Technology Limited Particulate hybrid hiv antigens
ATE91304T1 (de) * 1987-02-27 1993-07-15 Merck & Co Inc Verfahren zur herstellung des pres 1/s2/shepatitis-b-antigens aus hefe.
US5026828A (en) * 1987-02-27 1991-06-25 Merck & Co., Inc. Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
IL86832A (en) 1987-06-22 2002-09-12 Medeva Holdings Bv A recombinant DNA molecule containing a nucleotide sequence of part of the region encoding HBV pre-1s, an immunogenic particle containing multiple peptide monomers containing a pre-s1 epitope and pharmaceutical preparations containing it
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
NZ228948A (en) * 1988-05-13 1991-06-25 Phillips Petroleum Co Hbv particles containing s and pre-s 2 proteins and recombinant processes for their production in yeast cells
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2270892A1 (en) * 1974-05-14 1975-12-12 Inst Francais D Immunologie Vaccines from attenuated viruses - which have been serially incubated with yeast cells, especially Saccharomyces cerevisiae
JP2530801B2 (ja) * 1978-12-22 1996-09-04 バイオゲン インコーポレイテッド 組換えｄｎａ分子
IE52036B1 (en) * 1979-05-24 1987-05-27 Univ California Non-passageable viruses
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
JPH0314840A (ja) * 1988-12-28 1991-01-23 Kureha Chem Ind Co Ltd 弗化ビニリデン系ポリマー二軸冷延伸フィルムおよびその製造方法

Also Published As

Publication number Publication date
ATE123225T1 (de) 1995-06-15
JPS5877823A (ja) 1983-05-11
ES8400877A1 (es) 1983-11-16
ES514712A0 (es) 1983-11-16
DE3280468T2 (de) 1995-12-07
EP0072318B1 (en) 1990-05-30
IE65996B1 (en) 1995-11-29
DK114791D0 (da) 1991-06-14
GR76274B (da) 1984-08-04
PT75374A (en) 1982-09-01
DE3280468D1 (de) 1995-07-06
PT75374B (en) 1985-12-13
JPH0526798B2 (da) 1993-04-19
EP0072318A2 (en) 1983-02-16
DK347682A (da) 1983-02-05
HK64591A (en) 1991-08-23
EP0072318A3 (en) 1983-03-16
SG58191G (en) 1993-02-19
DE3280186D1 (de) 1990-07-05
DK163931B (da) 1992-04-21
DK163931C (da) 1992-09-14
CA1341642C (en) 2023-02-21
DK169152B1 (da) 1994-08-29

Similar Documents

Publication Publication Date Title
DK114791A (da) Fremgangsmaade til fremstilling af et antistof mod hbsag
EP0291586A3 (en) Recombinant hepatitis b surface antigen and vaccine containing it
IL95153A0 (en) Novel antigens and their production
AU3473489A (en) Expression of hepatisis b s and pres2proteins in methylotrophic yeasts
ATE91718T1 (de) Rekombinante dns-molekuele die hepatitis-boberfl|chenantigenkodieren, deren herstellung und abgeleitete vakzine.
EP0248410A3 (en) Improved yeast promoter and proces for preparing heterologous protein
EP0340806A3 (en) Synthesis of human virus antigens by yeast
ATE75787T1 (de) Verfahren zur herstellung von silizium-carbidwhiskern.
ATE109353T1 (de) Verfahren zur herstellung eines impfstoffs gegen hepatitis b.
JPS57209298A (en) Recombinant dna, its preparation, and host transformed therewith

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired